Berta Strulovici, Vice-President Research, Automated Biotechnology Dept, Merck & Co. speaks with NGP, and provides some insight into the recent emergence of MicroRNA.
Biomarkers are playing an increasingly important role in the development of new drugs to fight disease. In this revealing interview, Dr. Werner Kroll, Global Head of Biomarker Development at Novartis, gives us his view on the development of this exciting new area of medicine.
NGP catches up with Geoff Odell, Chairman of the LSIT Global Institute and CIO of the Novartis Genomic Research Institute, to discover how instrumental IT is to the life science drug pipeline.